FDA records indicate that there are no current recalls for this drug.
Are you a medical professional?
Trending Topics
Centussin Dhc Recall
Get an alert when a recall is issued.
Questions & Answers
Side Effects & Adverse Reactions
General: Considerable caution should be exercised in patients with hypertension, diabetes mellitus,
ischemic heart disease, hyperthyroidism, increased intraocular pressure and prostatic hypertrophy.
The elderly (60 years and older) are more likely to exhibit adverse reactions. Antihistamines may
cause excitability, especially in children. At dosages higher than the recommended dose,
nervousness, dizziness, or sleeplessness may occur.
Usage in Ambulatory Patients: Dihydrocodeine may impair the mental and/or physical abilities
required for the performance of potentially hazardous tasks such as driving a car or operating
machinery.
Respiratory Depression: Respiratory depression is the most dangerous acute reaction produced by
opioid agonist preparations, although it is rarely severe with usual doses. Opioids decrease the
respiratory rate, tidal volume, minute ventilation, and sensitivity to carbon dioxide. Respiratory
depression occurs most frequently in elderly more debilitated patients, usually after large initial doses
in non-tolerant patients, or when opioids are given in conjunction with other agents that depress
respiration. This combination product should be used with caution in patients with significant chronic
obstructive pulmonary disease or cor pulmonale and in patients with a substantially decreased
respiratory reserve, hypoxia, hypercapnia, or respiratory depression.
Hypotensive Effect: Dihydrocodeine, like all opioid analgesics, may cause hypotension in patients
whose ability to maintain blood pressure has been compromised by a depleted blood volume or who
receive concurrent therapy with drugs such as phenothiazines or other agents which compromise
vasomotor tone. CENTUSSIN DHC Liquid may produce orthostatic hypotension in ambulatory
patients. This combination product should be administered with caution to patients in circulatory
shock, since vasodilation produced by the drug may further reduce cardiac output and blood pressure.
Dependence: Dihydrocodeine can produce drug dependence of the codeine type and has the potential
of being abused. This product should be prescribed and administered with the appropriate degree of
caution. (See Drug Abuse and Dependence section).
Legal Issues
There is currently no legal information available for this drug.
FDA Safety Alerts
There are currently no FDA safety alerts available for this drug.
Manufacturer Warnings
There is currently no manufacturer warning information available for this drug.
FDA Labeling Changes
There are currently no FDA labeling changes available for this drug.
Uses
CENTUSSIN DHC Liquid is indicated to control cough and provide for temporary relief from
congestion associated with the upper respiratory tract.
History
There is currently no drug history available for this drug.
Other Information
NDC 23359-018-16
Rx Only
CV
DESCRIPTION:
Each 5 mL (one teaspoonful) for oral administration contains:
Dihydrocodeine Bitartrate*........................ 3 mg
*(WARNING- May be habit forming)
Brompheniramine Maleate........................ 4 mg
Phenylephrine Hydrochloride................... 7.5 mg
CENTUSSIN DHC Liquid also contains: Glycerin, Propylene Glycol, Sorbitol, Citric Acid, Sodium Citrate,
Sodium Saccharin, Grape Flavor, Purified Water.
Dihydrocodeine Bitartrate is an antitussive with the chemical name (Morphinan-6-ol,4,5-epoxy-3-methoxy-
17-methyl-, (5α, 6α)-2,3-dihydroxybutanedioate (1:1) (salt). It has the following structural formula:
Brompheniramine Maleate is an antihistamine having the chemical name, 2-Pyridinepropanamine,
γ-(4-bromophenyl)-N, N-dimethyl-, (±)-,(Z)-2-butenedioate (1:1). With the following structure:
Phenylephrine hydrochloride is an orally effective nasal decongestant. Chemically it is (-)-m-Hydroxy-α-
[(methylamino)methyl]benzyl alcohol hydrochloride. Its chemical structure is as follows:
Sources
Centussin Dhc Manufacturers
-
Centurion Labs, Llc
Centussin Dhc | Centurion Labs, Llc
Adults and Children 12 years of age or older:
1 teaspoonful every 4 to 6 hours. Not to exceed 6 teaspoonfuls in a 24 hour period.
Children 6 to 12 years of age: 1/2 teaspoonful every 4 to 6 hours. Not to exceed
3 teaspoonfuls in a 24 hour period.
Not recommended for children under 6 years of age.
*In mild cases or in particularly sensitive patients, less frequent or reduced doses may be
appropriate and adequate.
Login To Your Free Account